Bickling Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $934K | Sell |
33,087
-4,455
| -12% | -$126K | 0.58% | 35 |
|
|
2022
Q3 | $1.24M | Sell |
37,542
-894
| -2% | -$29.4K | 0.83% | 30 |
|
|
2022
Q2 | $1.21M | Sell |
38,436
-988
| -3% | -$31.1K | 0.77% | 31 |
|
|
2022
Q1 | $1.81M | Sell |
39,424
-3,192
| -7% | -$147K | 0.93% | 25 |
|
|
2021
Q4 | $2.61M | Sell |
42,616
-6,129
| -13% | -$375K | 1.27% | 20 |
|
|
2021
Q3 | $3.64M | Sell |
48,745
-4,386
| -8% | -$328K | 1.85% | 15 |
|
|
2021
Q2 | $4.92M | Buy |
53,131
+32
| +0.1% | +$2.96K | 2.22% | 13 |
|
|
2021
Q1 | $4.71M | Buy |
53,099
+11,349
| +27% | +$1.01M | 2.37% | 13 |
|
|
2020
Q4 | $3.89M | Buy |
+41,750
| New | +$3.89M | 2.4% | 11 |
|